Stokes Family Office’s Clorox CLX Stock Holding History

Stokes Family Office’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,590	Closed	-$307K	–	219
2021 Q1	$307K	Buy	+1,590	New	+$306K	0.05%	161

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stokes Family Office's CLX Position: Q2 2021 in Review

Stokes Family Office sold out of Clorox (CLX) in Q2 2021, closing a stake of 1,590 shares — an estimated $307K sold.

Stokes Family Office first reported a position in CLX in Q1 2021 and held it in 1 quarter. The position peaked at $307K in Q1 2021. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Stokes Family Office reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Stokes Family Office sold 1,590 Clorox shares in Q2 2021, an estimated $307K.
Stokes Family Office first reported a position in Clorox in Q1 2021 and held it in 1 quarter.
Stokes Family Office's Clorox position peaked at $307K in Q1 2021.
1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Stokes Family Office's 13F filing for Q2 2021, filed 12 Aug 2021.